{"id":105413,"date":"2021-05-12T04:43:48","date_gmt":"2021-05-12T04:43:48","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=105413"},"modified":"2022-05-11T05:34:11","modified_gmt":"2022-05-11T05:34:11","slug":"bromocriptine-mesylate","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/","title":{"rendered":"Bromocriptine mesylate"},"content":{"rendered":"<p>A dopamine receptor agonist that is a semisynthetic ergot alkaloid. It is used in the treatment of Parkinson\u2019s disease. It is also an inhibitor of prolactin release and growth hormone release.<\/p>\n<hr \/>\n<p>An ergot derivative that suppresses secretion of prolactin. It has been used to treat patients with hyperprolactinemia (e.g., in those with pituitary adenomas); to stimulate ovulation in patients with amenorrhea; to treat patients with acromegaly; and to treat patients with parkinsonism, as an adjunct to levodopa. Common side effects include nausea, dizziness, and headache.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A dopamine receptor agonist that is a semisynthetic ergot alkaloid. It is used in the treatment of Parkinson\u2019s disease. It is also an inhibitor of prolactin release and growth hormone release. An ergot derivative that suppresses secretion of prolactin. It has been used to treat patients with hyperprolactinemia (e.g., in those with pituitary adenomas); to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-105413","post","type-post","status-publish","format-standard","hentry","category-b"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bromocriptine mesylate - Definition of Bromocriptine mesylate<\/title>\n<meta name=\"description\" content=\"A dopamine receptor agonist that is a semisynthetic ergot alkaloid. It is used in the treatment of Parkinson\u2019s disease. It is also an inhibitor of prolactin release and growth hormone release.An ergot derivative that suppresses secretion of prolactin. It has been used to treat patients with hyperprolactinemia (e.g., in those with pituitary adenomas); to stimulate ovulation in patients with amenorrhea; to treat patients with acromegaly; and to treat patients with parkinsonism, as an adjunct to levodopa. Common side effects include nausea, dizziness, and headache.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bromocriptine mesylate - Definition of Bromocriptine mesylate\" \/>\n<meta property=\"og:description\" content=\"A dopamine receptor agonist that is a semisynthetic ergot alkaloid. It is used in the treatment of Parkinson\u2019s disease. It is also an inhibitor of prolactin release and growth hormone release.An ergot derivative that suppresses secretion of prolactin. It has been used to treat patients with hyperprolactinemia (e.g., in those with pituitary adenomas); to stimulate ovulation in patients with amenorrhea; to treat patients with acromegaly; and to treat patients with parkinsonism, as an adjunct to levodopa. Common side effects include nausea, dizziness, and headache.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-12T04:43:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-11T05:34:11+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/\",\"name\":\"Bromocriptine mesylate - Definition of Bromocriptine mesylate\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-12T04:43:48+00:00\",\"dateModified\":\"2022-05-11T05:34:11+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A dopamine receptor agonist that is a semisynthetic ergot alkaloid. It is used in the treatment of Parkinson\u2019s disease. It is also an inhibitor of prolactin release and growth hormone release.An ergot derivative that suppresses secretion of prolactin. It has been used to treat patients with hyperprolactinemia (e.g., in those with pituitary adenomas); to stimulate ovulation in patients with amenorrhea; to treat patients with acromegaly; and to treat patients with parkinsonism, as an adjunct to levodopa. Common side effects include nausea, dizziness, and headache.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bromocriptine mesylate\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bromocriptine mesylate - Definition of Bromocriptine mesylate","description":"A dopamine receptor agonist that is a semisynthetic ergot alkaloid. It is used in the treatment of Parkinson\u2019s disease. It is also an inhibitor of prolactin release and growth hormone release.An ergot derivative that suppresses secretion of prolactin. It has been used to treat patients with hyperprolactinemia (e.g., in those with pituitary adenomas); to stimulate ovulation in patients with amenorrhea; to treat patients with acromegaly; and to treat patients with parkinsonism, as an adjunct to levodopa. Common side effects include nausea, dizziness, and headache.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/","og_locale":"en_US","og_type":"article","og_title":"Bromocriptine mesylate - Definition of Bromocriptine mesylate","og_description":"A dopamine receptor agonist that is a semisynthetic ergot alkaloid. It is used in the treatment of Parkinson\u2019s disease. It is also an inhibitor of prolactin release and growth hormone release.An ergot derivative that suppresses secretion of prolactin. It has been used to treat patients with hyperprolactinemia (e.g., in those with pituitary adenomas); to stimulate ovulation in patients with amenorrhea; to treat patients with acromegaly; and to treat patients with parkinsonism, as an adjunct to levodopa. Common side effects include nausea, dizziness, and headache.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/","og_site_name":"Glossary","article_published_time":"2021-05-12T04:43:48+00:00","article_modified_time":"2022-05-11T05:34:11+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/","name":"Bromocriptine mesylate - Definition of Bromocriptine mesylate","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-12T04:43:48+00:00","dateModified":"2022-05-11T05:34:11+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A dopamine receptor agonist that is a semisynthetic ergot alkaloid. It is used in the treatment of Parkinson\u2019s disease. It is also an inhibitor of prolactin release and growth hormone release.An ergot derivative that suppresses secretion of prolactin. It has been used to treat patients with hyperprolactinemia (e.g., in those with pituitary adenomas); to stimulate ovulation in patients with amenorrhea; to treat patients with acromegaly; and to treat patients with parkinsonism, as an adjunct to levodopa. Common side effects include nausea, dizziness, and headache.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/bromocriptine-mesylate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Bromocriptine mesylate"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/105413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=105413"}],"version-history":[{"count":3,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/105413\/revisions"}],"predecessor-version":[{"id":158473,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/105413\/revisions\/158473"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=105413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=105413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=105413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}